COVID-19 is more severe in men, specifically in the age group at risk for prostate cancer, according to several studies. This knowledge will lead to better management of COVID-19 in prostate cancer patients. A review paper published in //Nature- Communications Biology summarizes recent developments and research and provides just-in-time considerations of our current understanding in three areas:
- epidemiological and biological evidence for gender and/or sex disparity in COVID-19 disease
- potential association between COVID-19 and prostate cancer molecular pathogenesis
- current therapeutic options for COVID-19 patients and, in particular, COVID-19 patients with prostate cancer
‘COVID-19 is more severe in prostate cancer patients and men. Male hormones may be responsible for the severity of the disease.’
Read More..Tweet it Now
Data from around the world has confirmed that men face a greater risk of severe illness from COVID-19 than women. Researchers have zeroed in on a possible reason: Androgen—male hormones such as testosterone—appear to boost the virus’ ability to get inside cells.Read More..
At the same time, a gene known as TMPRSS2 is also highly expressed in both COVID-19 and prostate cancer. In fact, these issues may be related—more androgen could signify greater expression of TMPRSS2 which could create a higher susceptibility to the virus.
Prostate cancer patients belong to the age group that is more susceptible to SARS-CoV-2 infection and, given their cancer, are at a higher risk of developing severe illness due to a weak immune system. The particular vulnerability of older men to COVID-19 compels us to advocate for routine screening of the disease in prostate cancer patients.
Experts are on the trail of a mechanism for this male bias—an effort led by prostate cancer researchers. The study of gender-based and sex-based differences in COVID-19 is a priority, since better understanding of these disparities will help in the development of better therapeutic strategies and vaccines, as well as public health policies.
In conclusion, COVID-19 affects both sexes, and every age group and ethnicity, albeit to varying degrees. COVID-19 disease burden is disproportionately higher in men, and adverse outcomes are further compounded by older age and co-morbidities.
Advertisement
Source-Newswise